The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for NeilMed Pharmaceuticals sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights NeilMed Pharmaceuticals Inc, United States Revenue

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

NeilMed Pharmaceuticals Inc (NeilMed) is a manufacturer and supplier of large volume low pressure saline nasal irrigation systems. The company’s products include ear care, adult nasal irrigation isotonic, adult nasal irrigation extra strength hypertonic, babies and children nasal irrigation, sterile saline spray, dry nose, electrical irrigator, accessories and devices. It also provides nasal decongestant spray products that help in reducing common nasal and sinus. NeilMed supports medical research at various university medical centers. The company markets its products through a network of distributors across Canada, Australia, New Zealand, the UK, Ireland, Poland, Singapore, Malaysia, and others. NeilMed is headquartered in Santa Rosa, California, the US. Key subsidiaries of NeilMed Pharmaceuticals include Neoss, NeilMed Pharmaceuticals, NeilMed Devices, NeilMed Pharmaceuticals and NeilMed Pharmaceuticals New Zealand.

The key metrics of NeilMed Pharmaceuticals related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As NeilMed Pharmaceuticals is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as NeilMed Pharmaceuticals.

For a detailed understanding of the performance of NeilMed Pharmaceuticals, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.